University of Warwick spinout company CytoSwim is developing innovative single-use chips for sperm conditioning and separation, an integral part of IVF procedures used in both animal breeding and human assisted reproduction treatments.

Medherant has completed two Phase I clinical studies with its novel transdermal drug delivery technology, the TEPI Patch®. There is considerable interest in the transdermal delivery of drugs to overcome some of the disadvantages of oral administration, such as spikes in drug levels that can lead to side effects, and poor compliance.